Kurt Karst presenting at the CBI Inaugural Forum on Pre-Approval Expanded Access Programmes for the Bio/Pharmaceutical Industry

Understanding the Role of EMEA and FDA During Patient Compassionate Use and Expanded Access

When

November 18, 2009

Kurt Karst will be presenting on “Understanding the Role of EMEA and FDA During Patient Compassionate Use and Expanded Access” at the CBI Inaugural Forum on Pre-Approval Expanded Access Programmes for the Bio/Pharmaceutical Industry.

London, United Kingdom